scholarly article | Q13442814 |
P356 | DOI | 10.1038/SJ.ONC.1201877 |
P953 | full work available at URL | https://www.nature.com/articles/1201877 |
https://www.nature.com/articles/1201877.pdf | ||
P698 | PubMed publication ID | 9681823 |
P5875 | ResearchGate publication ID | 13602978 |
P2093 | author name string | M. Sudol | |
D. Marchetti | |||
G. E. Gallick | |||
N. Parikh | |||
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | src family kinase | Q7582406 |
metastatic melanoma | Q18975855 | ||
P304 | page(s) | 3253-3260 | |
P577 | publication date | 1998-06-01 | |
1998-06-25 | |||
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells | |
P478 | volume | 16 |
Q89526875 | A Fyn biosensor reveals pulsatile, spatially localized kinase activity and signaling crosstalk in live mammalian cells |
Q40589019 | A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling |
Q43816439 | Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling. |
Q48191804 | Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells |
Q34114252 | Elevated c-Src and c-Yes expression in malignant skin cancers |
Q48983460 | Expression of N-myristoyltransferase in human brain tumors |
Q34998047 | Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3 |
Q48467128 | Identification of melanoma initiating cells: does CD271 have a future? |
Q31119738 | Identification of potent Yes1 kinase inhibitors using a library screening approach |
Q36865568 | LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma |
Q55078672 | Mapping of melanoma modifier loci in RET transgenic mice. |
Q96950900 | Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways |
Q40556932 | Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas |
Q48721201 | Neurotrophins and Neurotrophin Receptors in Human Lung Cancer |
Q33361997 | Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors |
Q36825525 | Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration |
Q36940730 | Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines |
Q34781153 | Predictive biomarkers for dasatinib treatment in melanoma |
Q44774251 | Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells |
Q73141299 | Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells |
Q35539318 | Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies |
Q30175265 | The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes |
Q27334481 | The p75 neurotrophin receptor is a central regulator of glioma invasion |
Q48191239 | Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor |
Q40426949 | Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma |
Search more.